TO CHECK THE PAIN RELIVING ACTION OF ROPIVACAINE VERSUS LEVOBUPIVACAINE IN PATIENT UNDERGOING BREAST SURGERY.
Not Applicable
Completed
- Conditions
- Health Condition 1: C50- Malignant neoplasm of breast
- Registration Number
- CTRI/2018/11/016311
- Lead Sponsor
- Department of Anesthesiology kidwai Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
ASA 1 and 2
Consenting patient
Weight 50-70kg
Exclusion Criteria
Patient refusal
History of allergy
Severe renal liver cardiac and pulmonary dysfunction
Unable to comprehend VAS scale
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analgesic efficacy VAS scaleTimepoint: Post operatively 0min, 15min, 30min, 45min, 60min,90min,2,4,8,12,16,20 and 24hours.
- Secondary Outcome Measures
Name Time Method Requirements of rescue analgesia <br/ ><br>Incidence and severity of side effectTimepoint: Post operative period in first 24hrs